v3.26.1
Income Taxes
 12 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
For the year ended March 31, 2026, the Company had federal and state NOL carryforwards of approximately $194.2 million and $195.1 million, respectively. Of these state NOLs, approximately $162.2 million, are expiring in various amounts from 2026 through 2045. The remaining federal and state NOLs of approximately $194.2 million and $32.9 million, respectively, have an indefinite life but the federal NOLs may only offset 80% of taxable income when used. For the year ended March 31, 2025, the Company incurred federal and state operating losses of approximately $275.1 million and $207.0 million, respectively, to offset future taxable income of which $241.1 million federal NOL and $40.3 million of state NOLs can be carried forward indefinitely but can only offset 80% of taxable income when used.
The Company has net deferred tax assets, before applying the valuation allowance, of approximately $64.8 million and $83.6 million relating principally to the NOLs as of March 31, 2026 and 2025, respectively. Federal NOL carryforwards may be subject to limitations as a result of the change in ownership that occurred in the year ended March 31, 2015, as defined under Internal Revenue Code Section 382. State NOL carryforwards are subject to limitations which differ from federal law in that they may not allow the carryback of net operating losses and have shorter carryforward periods.
Accounting Standards Codification Topic 740, Income Taxes (“ASC 740”), requires that a valuation allowance be recorded to reduce deferred tax assets when it is more likely than not that the tax benefit of the deferred tax assets will not be realized. The evaluation includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused. In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets. Since inception, the Company has mainly incurred tax losses which represents significant negative evidence toward the realizability of its deferred tax assets. Therefore, the Company continues to apply a full valuation allowance against its deferred tax assets as of March 31,
2026 and 2025, with the exception of the net deferred tax liability of approximately $6.3 million and $6.6 million, respectively, regarding indefinite-lived intangibles.
All remaining federal NOL carryforwards are indefinite lived. Utilization of these NOLs will be limited to 80% of future taxable income. The Company recorded $0.3 million and $0.6 million, respectively, of federal deferred tax expense during the years March 31, 2026 and 2025 and increased the federal deferred tax liability by the same amount due to the naked tax credit related to the indefinite-lived intangible. An analysis of the state NOL carryforwards revealed that most of them are not indefinite. The Company recorded $0.6 million and $0.3 million of state deferred tax benefit during the years March 31, 2026 and 2025 and decreased the state deferred tax liability by the same amount from the ability to use the state NOL carryforwards against the indefinite-lived intangible. This valuation allowance has no effect on the Company’s ability to utilize the deferred tax assets to offset future taxable income, if generated. As required by U.S. GAAP, the Company will continue to assess the likelihood that the deferred tax assets will be realizable in the future, and the valuation allowance will be adjusted accordingly. The tax benefits relating to any reversal of the valuation allowance on the net deferred tax assets in a future period will be recognized as a reduction of future income tax expense in that period.
On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA” or the “Act”) was signed into law. The Act introduces a broad range of changes to U.S. federal income tax law affecting corporations, including, among other provisions, the permanent reinstatement of 100% bonus depreciation for qualifying property acquired after January 19, 2025; the restoration of immediate expensing of domestic research and experimental expenditures; modifications to the business interest expense limitation under Section 163(j) and revisions to the international tax provisions.
In accordance with ASC 740, the Company recognizes the effects of changes in tax law in the period of enactment. The Company has evaluated the provisions of the OBBBA and, based on its current operations and tax position, does not expect the Act to have a material impact on its consolidated financial statements, results of operations, cash flows, or effective tax rate. The Company will continue to monitor forthcoming regulatory guidance, technical corrections, and state conformity developments, and will reassess the impact of the Act as additional information becomes available.
Net deferred tax assets and liabilities consist of the following as of March 31, 2026 and 2025 (in thousands):
20262025
Deferred tax asset
Property and equipment$670 $748 
Accrued expenses770 346 
Deferred revenue27,171 26,852 
Asset retirement obligations16 16 
Net operating loss carryforward52,623 70,267 
Operating lease liabilities1,310 1,529 
Charitable contributions carryforward3 3 
Stock compensation expense5,688 4,302 
Total deferred tax asset88,251 104,063 
Deferred tax liability
Right of use assets(1,175)(1,345)
Indefinite-lived intangible assets(22,263)(19,046)
Total deferred tax liability(23,438)(20,391)
Total deferred tax assets and liabilities64,813 83,672 
Valuation allowance(71,136)(90,278)
Net deferred tax assets and liabilities$(6,323)$(6,606)
The components of the income tax expense for the years ended March 31, 2026 and 2025 are as follows (in thousands):
20262025
Current:  
Federal$2,192 $— 
State3,162 1,567 
Total current5,354 1,567 
Deferred:
Federal309 621 
State(592)(296)
Total deferred(283)325 
Total income tax expense$5,071 $1,892 
The following table presents taxes paid by the Company net of refunds received after the adoption of ASU 2023-09 for the year ended March 31, 2026:
2026
Federal income taxes paid
$2,405 
State income taxes paid
Colorado
186 
Washington D.C.193 
Illinois1,925 
Minnesota638 
Virginia202 
Other jurisdictions(1)
259 
Total state income taxes paid
3,403 
Total income taxes paid (2)
$5,808 
1.Other jurisdictions include income taxes paid during the year for states that do not meet the 5% disaggregation threshold.
2.Income taxes paid include only taxes within the scope of ASC 740 net of refunds and exclude non-income based taxes such as excise and sales taxes.
The differences between the United States federal statutory tax rate and the Company’s effective tax rate for the year ended March 31, 2026 after the adoption of ASU 2023-09 are as follows (in thousands):
2026
Statutory federal tax$19,909 21 %
State income taxes, net of federal benefit (1)
1,955 2 %
Change in valuation allowance - Federal(18,952)-20 %
Nontaxable or nondeductible items
Incentive stock option expense301 — %
Other permanent differences34 — %
162M executive compensation limit92 — %
Intangibles - FCC licenses1,899 2 %
Other adjustments(167)— %
Total income tax expense$5,071 5 %
1.State taxes in Illinois made up greater than 50% of the tax effect in this category.
The differences between the United States federal statutory tax rate and the Company’s effective tax rate for the year ended March 31, 2025 before the adoption of ASU 2023-09 are as follows (in thousands):
2025
Statutory federal tax$(1,991)21 %
State income taxes, net of federal benefit
952 -10 %
Incentive stock option expense(195)2 %
Other permanent differences(61)1 %
162M executive compensation limit5,001 -53 %
Change in valuation allowance - Federal(1,692)18 %
Prior year adjustments(122)1 %
Total income tax expense$1,892 -20 %